(6-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyridin-3-yl)boronic acid, 95.0%, 1g

tert-butyl 4-amino-3-hydroxypiperidine-1-carboxylate, 98%, 1g

(S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride, 95.0%, 1g

n-(Pyridin-2-yl)benzamide, 98%, 5g

Butyl 2-cyanoacrylate, 95.0%, 25g

tert-Butyl (2S,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)pyrrolidine-1-carboxylate, 98%, 500mg

Methyl 4-Iodosalicylate>98.0%(GC)25g

(S)-1-BOC-2-Hydroxymethylpiperazine, 97.0%, 50g

N-Benzyl-1-(pyridin-2-yl)methanamine, 95+%, 1g

Methyl 6-methoxypyrimidine-4-carboxylate, 98%, 1g

Molybdenum rod 99.9+% 4.0 mm diameter 250 mm

(2-METHOXY-5-((4-METHYLPIPERIDIN-1-YL)SULFONYL)PHENYL)BORONIC ACID, 95%, 250mg

(S)-Perfluorophenyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoate, 98%, 5g